PL
AMGN icon

Parkwood LLC’s Amgen AMGN Stock Holding History

Parkwood LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,298
Closed -$494K – 445
2016
Q1 		$494K Sell
3,298
-132
-4% -$19.6K 0.08% 299
2015
Q4 		$557K Buy
3,430
+889
+35% +$140K 0.09% 194
2015
Q3 		$351K Sell
2,541
-217
-8% -$34.2K 0.06% 262
2015
Q2 		$423K Sell
2,758
-813
-23% -$130K 0.06% 235
2015
Q1 		$571K Buy
+3,571
New +$562K 0.07% 184
2014
Q4 		– Sell
-3,562
Closed -$500K – 485
2014
Q3 		$500K Buy
+3,562
New +$465K 0.11% 90

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Parkwood LLC's AMGN Position: Q2 2016 in Review

Parkwood LLC sold out of Amgen (AMGN) in Q2 2016, closing a stake of 3,298 shares — an estimated $494K sold.

Parkwood LLC first reported a position in AMGN in Q3 2014 and held it in 6 quarters. The position peaked at $571K in Q1 2015. 1,472 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

  • Parkwood LLC reported no remaining Amgen position as of Q2 2016 after selling out during the quarter.
  • Parkwood LLC sold 3,298 Amgen shares in Q2 2016, an estimated $494K.
  • Parkwood LLC first reported a position in Amgen in Q3 2014 and held it in 6 quarters.
  • Parkwood LLC's Amgen position peaked at $571K in Q1 2015.
  • 1,472 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Parkwood LLC's 13F filing for Q2 2016, filed 22 Jul 2016.